|
|
| MRD / Regn No. |
: 20260000694 |
Date |
: 23/07/2026 |
| Patient Name |
: Mousumi Das Malakar |
Age & Gender |
: 55 Yrs. / Female |
| Contact No. |
: 9434690261 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
|
Subjective |
: |
THYROID DYSFUNCTION SINCE 2007,DM FOR 3 YEARS |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,OBESITY,HYPOTHYROIDISM,INCREASED FIB4 SCORE |
|
Plan |
: |
MEDICATIONS AS PRESCRIBED,GET FIBROSCAN AND REVIEW WITH RESULTS |
|
| Salient Investigations |
: |
CREATININE: 0.63 mg/dL | HEMOGLOBIN: 12.8 g/dL | MCH: 28 pg | MCHC: 31 gm % | MCV: 90 fl | PCV: 41 % | PLATELETS: 158 thou cells/ ul | RBC COUNT: 4.56 million/ul | TOTAL COUNT WBC: 6.96 Cells/cmm | FASTING PLASMA GLUCOSE (FPG): 128 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.2 % | HIGH SENSITIVE C REACTIVE PROTEIN: 1.54 mg/L | BUN BLOOD UREA NITROGEN: 17.8 mg/dL | UREA: 38 mg/dL | A\G RATIO: 1.59 g/dl | ALBUMIN (SERUM): 4.36 g/dL | ALKALINE PHOSPHOTASE: 117 IU/L | DIRECT BILIRUBIN: 0.32 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 15 U/L | GLOBULIN: 2.74 g/dl | INDIRECT BILIRUBIN: 0.44 | SGOT (AST): 24 U/L | SGPT (ALT): 26 IU/L | TOTAL BILIRUBIN: 0.76 mg/dL | TOTAL PROTEIN: 7.100 g/dl | HDL HIGH DENSITY LIPOPROTEIN: 44 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 55 mg/dL | TGL TRIGLYCERIDE: 88 mg/dL | TOTAL CHO/HDL RATIO: 2.5 | TOTAL CHOLESTEROL: 110 mg/dl | VLDL: 18 mg/dl | POST PRANDIAL GLUCOSE (2HPP): 139 mg/dL | MICROALBUMIN CREATININE RATIO: 17.90 mcg/mg | VITAMIN D (25 OH): 20.9 ng/mL | NT PROBNP : 57 pg/mL | FREE T4 : 1.28 ng/dL | TSH : 1.050 mIU/L | CUP DISC RATIO L: 0.07 | CUP DISK RATIO R: 0.01 | EGFR EGLOMERULAR FILTRATION RATE: 104.91 mL/min/1.73m2 | FIB4: 1.64 | EGFR EGLOMERULAR FILTRATION RATE: 104.91 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 104.91 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 104.91 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 104.91 mL/min/1.73m2 | FIB4: 1.64 | FIB4: 1.64 | ABI LEFT: 1.07 | ABI RIGHT: 1.04 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
EMPAGLIFLOZIN 10 MG LINAGLIPTIN 5 MG
GLYXAMBI 10/5 |
|
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| EMPAGLIFLOZIN MAY CAUSE GENITOURINARY INFECTION KEEP GENITAL AREA CLEAN | |
|
2 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
3 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
4 |
TABLET TELMISARTAN 40 MG CHLORTHALIDONE 6.25
TAZLOC CT 40/6.25
Medicine For HYPERTENSION KIDNEY PROTECTION |
PO |
0-0-1 |
AT BEDTIME
|
|
|
|
5 |
TABLET THYROXINE 75 MCG
THYRONORM 75 MCG
Medicine For HYPOTHYROIDISM |
PO |
1-0-0 |
EMPTY STOMACH
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 24/Jul/2026 |
| Tests Suggested For Next Visit |
: FIBROSCAN OF THE LIVER PLEASE REPORT CAP SCORE AND FIBROSIS SCORE |
| |
|
| |
|
